glp 1 south korea warns teens of GLP-1 obesity drug risks and tightens prescription monitoring Lilly's diabetes drug Mounjaro receives

15 Months of Progress After 15 months of consistent treatment with Tirzepatide at a dose of 7.5 mg/week, JHs results were nothing short of inspiring: Follow-Up Bioimpedance Spectroscopy Measurements: Weight: 162 lbs (a 78-lb loss) Body Fat Percentage: 32.9% (down 12.8%) BMI: 23.3 (a reduction of 10.1 kg/m) Body Fat Mass: 53.2 lbs (a decrease of 56 lbs) Lean Body Mass: 109 lbs (down 21 lbs) Skeletal Muscle Mass: 59 lbs (loss of only 12 lbsjust 15% of her total weight loss, less than the typical 20%) ECW/TBW: Slight improvement in the right leg to 0.396

The total amount of Retatrutide (6mg) remains the same in the vial

We also used L1 regularization to generate a model with the least number of features

doi: 10.1016/j.metabol.2009.12.019 411 KitamiTFukudaSKatoTYamagutiKNakatomiYYamanoEet al